Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Regina Wikinski

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Archives of Medical Research|December 10, 2008
Metalloproteases 2 and 9, Lp-PLA(2) and lipoprotein profile in coronary patientsMaria Luz Muzzio, Veronica Miksztowicz, Fernando Brites, et al.
Metabolic Syndrome and Related Disorders|March 8, 2014
Do insulin resistance conditions further impair the lipid and inflammatory profile in end-stage renal disease patients on hemodialysis?Leonardo Cacciagiú, Ana I González, Alicia Elbert, et al.
Atherosclerosis|May 29, 2007
Endothelial and leukocyte adhesion molecules in primary hypertriglyceridemiaMaría Belén Benítez, Luis Cuniberti, María Cecilia Fornari, et al.
Journal of Cardiovascular Pharmacology|February 4, 2009
Rosuvastatin given during reperfusion decreases infarct size and inhibits matrix metalloproteinase-2 activity in normocholesterolemic and hypercholesterolemic rabbitsVerónica D'Annunzio, Martín Donato, Lukas Erni, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 5, 2010
Pro-inflammatory and atherogenic circulating factors in non-alcoholic fatty liver disease associated to metabolic syndromeDiego Lucero, Valeria Zago, Graciela I López, et al.
Experimental Physiology|November 3, 2009
Role of matrix metalloproteinase-2 in the cardioprotective effect of ischaemic postconditioningMartín Donato, Verónica D'Annunzio, Bruno Buchholz, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 17, 2010
Does non-alcoholic fatty liver impair alterations of plasma lipoproteins and associated factors in metabolic syndrome?Diego Lucero, Valeria Zago, Graciela I López, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Archives of Medical Research|December 10, 2008
Metalloproteases 2 and 9, Lp-PLA(2) and lipoprotein profile in coronary patientsMaria Luz Muzzio, Veronica Miksztowicz, Fernando Brites, et al.
Metabolic Syndrome and Related Disorders|March 8, 2014
Do insulin resistance conditions further impair the lipid and inflammatory profile in end-stage renal disease patients on hemodialysis?Leonardo Cacciagiú, Ana I González, Alicia Elbert, et al.
Atherosclerosis|May 29, 2007
Endothelial and leukocyte adhesion molecules in primary hypertriglyceridemiaMaría Belén Benítez, Luis Cuniberti, María Cecilia Fornari, et al.
Journal of Cardiovascular Pharmacology|February 4, 2009
Rosuvastatin given during reperfusion decreases infarct size and inhibits matrix metalloproteinase-2 activity in normocholesterolemic and hypercholesterolemic rabbitsVerónica D'Annunzio, Martín Donato, Lukas Erni, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 5, 2010
Pro-inflammatory and atherogenic circulating factors in non-alcoholic fatty liver disease associated to metabolic syndromeDiego Lucero, Valeria Zago, Graciela I López, et al.
Experimental Physiology|November 3, 2009
Role of matrix metalloproteinase-2 in the cardioprotective effect of ischaemic postconditioningMartín Donato, Verónica D'Annunzio, Bruno Buchholz, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 17, 2010
Does non-alcoholic fatty liver impair alterations of plasma lipoproteins and associated factors in metabolic syndrome?Diego Lucero, Valeria Zago, Graciela I López, et al.
Pageof 2